Diagnosis and treatment of the neuromuscular manifestations of Lyme disease

Current Treatment Options in Neurology

Volumn 9, Issue 2, 2007, Pages 93-100

  Halperin, John J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; DOXYCYCLINE; MACROLIDE; PENICILLIN G; PLACEBO; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BLOOD BRAIN BARRIER; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; CRANIAL NEUROPATHY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG PENETRATION; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LYME DISEASE; MENINGITIS; META ANALYSIS; NEURITIS; NEUROMUSCULAR DISEASE; NONHUMAN; REVIEW; SERODIAGNOSIS; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; WESTERN BLOTTING;

EID: 33847627567     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-007-0035-0     Document Type: Review

References (42)

1. Ceftriaxone-associated biliary complications of treatment of suspected disseminated Lyme disease - New Jersey, 1990-1992. MMWR Morb Mortal Wkly Rep 1993, 42:39-42.
2. Garin C, Bujadoux A: Paralysie par les tiques. J Med Lyon 1922, 71:765-767.
3. Burgdorfer W, Barbour AG, Hayes SF, et al.: Lyme disease: a tick borne spirochetosis? Science 1982, 216:1317-1319.
4. Hellerstrom S: Erythema migrans Afzelius with meningitis. Acta Derm Venereol (Stockholm) 1951, 31:227-234.
5. Halperin JJ, Luft BJ, Volkman DJ, Dattwyler RJ: Lyme neuroborreliosis - peripheral nervous system manifestations. Brain 1990, 113:1207-1221.
6. Wormser GP, Dattwyler RJ, Shapiro ED, et al.: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1089-1134.
7. Halperin JJ, Shapiro ED, Logigian EL, et al.: Practice parameter: treatment of nervous system Lyme disease. Neurology 2007, In press.
8. Rand PW, Lubelczyk C, Holman MS, et al.: Abundance of Ixodes scapularis (Acari: Ixodidae) after the complete removal of deer from an isolated offshore island, endemic for Lyme disease. J Med Entomol 2004, 41:779-784.
9. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997, 46:1-55.
10. Gerber MA, Shapiro ED, Burke GS, et al.: Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 1996, 335:1270-1274.
11. Steere AC, Sikand VK: The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med 2003, 348:2472-2474.
12. Steere AC, Malawista SE, Hardin JA, et al.: Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med 1977, 86:685-698.
13. Lyme disease - United States, 2001-2002. MMWR Morb Mortal Wkly Rep 2004, 53:365-369.
14. Reik L, Steere AC, Bartenhagen NH, et al.: Neurologic abnormalities of Lyme disease. Medicine 1979, 58:281-294.
15. Skogman BH, Croner S, Odkvist L: Acute facial palsy in children - a 2-year follow-up study with focus on Lyme neuroborreliosis. Int J Pediatr Otorhinolaryngol 2003, 67:597-602.
16. Kalina P, Decker A, Kornel E, Halperin JJ: Lyme disease of the brainstem. Neuroradiology 2005, 47:903-907.
17. Halperin J, Logigian E, Finkel M, Pearl R: Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology 1996, 46:619-627.
18. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995, 44:590-591.
19. Peltomaa M, McHugh G, Steere AC: The V1sE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis. Otol Neurotol 2004, 25:838-841.
20. Dressler F, Whalen JA, Reinhardt BN, Steere AC: Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993, 167:392-400.
21. Halperin JJ: Lyme disease and the peripheral nervous system. Muscle Nerve 2003, 28:133-143.
22. Eiffert H, Karsten A, Schlott T, et al.: Acute peripheral facial palsy in Lyme disease - a distal neuritis at the infection site. Neuropediatrics 2004, 35:267-273.
23. Halperin JJ: Facial nerve palsy associated with Lyme disease. Muscle Nerve 2003, 28:516-517.
24. Sibony P, Halperin J, Coyle P, Patel K: Reactive Lyme serology in optic neuritis. J Neuroophthalmol 2005, 25:71-82.
25. Jalladeau E, Pradat PF, Maisonobe T, Leger JM: Multiple mononeuropathy and inflammatory syndrome manifested in Lyme disease. Rev Neurol (Paris) 2001, 157:1290-1292.
26. Mormont E, Esselinckx W, De Ronde T, et al.: Abdominal wall weakness and lumboabdominal pain revealing neuroborreliosis: a report of three cases. Clin Rheumatol 2001, 20:447-450.
27. Gutknecht J, De Wazieres B, Fest T, Dupond JL: Guillain-Barré syndrome associated with Lyme disease. Presse Med 1994, 23:490.
28. Shapiro EE: Guillain-Barré syndrome in a child with serologic evidence of Borrelia. Pediatr Infect Dis J 1998, 17:264-265.
29. England JD, Bohm RP, Roberts ED, Philipp MT: Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol 1997, 41:375-384.
30. Vallat JM, Hugon J, Lubeau M, et al.: Tick bite meningoradiculoneuritis. Neurology 1987, 37:749-753.
31. Roberts ED, Bohm RP Jr, Lowrie RC Jr, et al.: Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 1998, 178:722-732.
32. Holmgren AR, Matteson EL: Lyme myositis. Arthritis Rheum 2006, 54:2697-2700.
33. Karlsson M, Hammers S, Nilsson-Ehle I, et al.: Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis. Antimicrob Agents Chemother 1996, 40:1104-1107.
34. Klempner M, Hu L, Evans J, et al.: Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001, 345:85-92.
35. Kaplan RF, Trevino RP, Johnson GM, et al.: Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology 2003, 60:1916-1922.
36. Krupp LB, Hyman LG, Grimson R, et al.: Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003, 60:1923-1930.
37. Fallon B, Sackheim H, Keilp J, et al.: Double-blind placebo-controlled retreatment with IV ceftriaxone for Lyme encephalopathy: clinical outcome. In Proceedings of the 10th International Conference on Lyme Borreliosis and Other Tick-borne Diseases. Vienna, Austria; 2005:196.
38. Halperin JJ: Treatment of neuroborreliosis. Curr Treat Options Neurol 1999, 1:139-145.
39. Borg R, Dotevall L, Hagberg L, et al.: Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis 2005, 37:449-454.
40. Dotevall L, Hagberg L: Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 1999, 28:569-574.
41. Karkkonen K, Stiernstedt S, Karlsson M: Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis 2001, 33:259-262.
42. Karlsson M, Hammers-Berggren S, Lindquist L, et al.: Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994, 44:1203-1207.